MARKET

BBC

BBC

Virtus LifeSci Biotech Clinical Trls ETF
NYSEARCA

Real-time Quotes | Provided by Morningstar

50.32
0.00
0.00%
Opening 09:30 06/21 EDT
OPEN
--
PREV CLOSE
50.59
HIGH
--
LOW
--
VOLUME
0
TURNOVER
--
52 WEEK HIGH
62.60
52 WEEK LOW
35.67
TOTAL ASSET
40.88M
YTD YIELD
0.44%
1D
5D
1M
3M
1Y
5Y
Roche's Accu-Chek Inform II System OK'd in Canada for intensive care use
Health Canada approves Roche's (RHHBY) Accu-Chek Inform II Hospital Blood Glucose System system for Critically ill Care Use.With this new claim, healthcare professionals using the Accu-Chek Infor II System can continue to deliver accurate and
Seekingalpha · 06/09 12:18
Biotech ETFs Surge on Biogen's Alzheimer Drug Approval
Zacks.com · 06/08 14:15
Best Biotech ETFs for Q2 2021
Investopedia · 02/03 18:47
Saudi Wealth Fund Making Another Splash, This Time at Home
Bloomberg · 11/17/2020 14:58
Traders Shorting VIX Spur Inflows to $1.2 Billion Fund Down 34%
Bloomberg · 11/17/2020 13:04
Saudi Wealth Fund Cuts U.S. Stock Holdings, Holds On to Uber
Bloomberg · 11/17/2020 05:21
Tesla Is So Huge It May Take Two Steps to Put It in the S&P 500
Bloomberg · 11/17/2020 00:09
Hedge Funds Bet on Tech Ahead of Unpredictable Fourth Quarter
Bloomberg · 11/16/2020 23:08
More
No Data
Learn about the latest financial forecast of BBC. Analyze the recent business situations of Virtus LifeSci Biotech Clinical Trls ETF through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
No Data
Ratings
Date
Period
Agency
Ratings
08/31/2020
3 Year
Morningstar
08/31/2020
5 Year
Morningstar
  • Performance
  • Asset Allocation
  • Dividend History
Period
Return
Rank in Cat
1-Day
-4.3198%
--
1-Week
-2.8867%
--
1-Month
-6.1209%
--
3-Month
-7.1870%
--
6-Month
7.6456%
--
YTD
0.4368%
--
1-Year
47.4713%
--
5-Year
4.6049%
--
Since Inception
7.9926%
--
No Data
No Data
  • All
No Data
Profile
Fund Name
Virtus LifeSci Biotech Clinical Trls ETF
Risk
High Risk
Inception Date
2014-12-16
Benchmark
NASDAQ Composite CR
Advisor Company
Virtus
Custodian
The Bank of New York Mellon
Manager
Brown/Kadushin